This paper is in the following e-collection/theme issue:

Transdiagnostic Mental Health Interventions (182) Chatbots and Conversational Agents (589) Depression and Mood Disorders; Suicide Prevention (1466) Anxiety and Stress Disorders (1138) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (1701) Mental Health Issues in Adolescence (497)

Published on in Vol 12 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/63515, first published .
Evaluation of a Guided Chatbot Intervention for Young People in Jordan: Feasibility Randomized Controlled Trial

Evaluation of a Guided Chatbot Intervention for Young People in Jordan: Feasibility Randomized Controlled Trial

Evaluation of a Guided Chatbot Intervention for Young People in Jordan: Feasibility Randomized Controlled Trial

Authors of this article:

Anne Marijn de Graaff1 Author Orcid Image ;   Rand Habashneh2 Author Orcid Image ;   Sarah Fanatseh2 Author Orcid Image ;   Dharani Keyan1, 3 Author Orcid Image ;   Aemal Akhtar3, 4 Author Orcid Image ;   Adnan Abualhaija2 Author Orcid Image ;   Muhannad Faroun2 Author Orcid Image ;   Ibrahim Said Aqel2 Author Orcid Image ;   Latefa Dardas5 Author Orcid Image ;   Chiara Servili1 Author Orcid Image ;   Mark van Ommeren1 Author Orcid Image ;   Richard Bryant3 Author Orcid Image ;   Kenneth Carswell1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Anne Marijn de Graaff   1 * , MSc ;   Rand Habashneh   2 * , MSc ;   Sarah Fanatseh   2 , BSc ;   Dharani Keyan   1, 3 , PhD ;   Aemal Akhtar   3, 4 , PhD ;   Adnan Abualhaija   2 , MSc ;   Muhannad Faroun   2 , PhD ;   Ibrahim Said Aqel   2 , PhD ;   Latefa Dardas   5 , PhD ;   Chiara Servili   1 , PhD ;   Mark van Ommeren   1 , PhD ;   Richard Bryant   3 , DSc ;   Kenneth Carswell   1 , DClinPsy

1 Department of Mental Health, Brain Health and Substance Use, World Health Organization, Geneva, Switzerland

2 Institute for Family Health, King Hussein Foundation, Amman, Jordan

3 School of Psychology, University of New South Wales, Sydney, Australia

4 Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden

5 Community Health Nursing Department, School of Nursing, University of Jordan, Amman, Jordan

*these authors contributed equally

Corresponding Author:

  • Anne Marijn de Graaff, MSc
  • Department of Mental Health, Brain Health and Substance Use
  • World Health Organization
  • Av. Appia 20
  • Geneva, 1211
  • Switzerland
  • Phone: 41 792493513
  • Email: degraaffa@who.int